Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
EFA vs VEA: Weighing the Key Differences Between These Developed Markets ETFs

EFA vs VEA: Weighing the Key Differences Between These Developed Markets ETFs

Key Takeaways

  • EFA tracks the MSCI EAFE Index, which excludes both the U.S. and Canada and treats South Korea as an emerging market; VEA tracks the FTSE Developed All Cap ex US Index, which includes Canada, South Korea, and small-cap stocks.
  • VEA is dramatically cheaper (0.03% expense ratio) and far more diversified (nearly 4,000 holdings) than EFA (0.32% and roughly 700–900 holdings).
  • Both are passive, market-capitalization-weighted developed-market ex-U.S. funds heavily concentrated in financials, industrials, healthcare, and technology.
  • EFA skews toward large- and mid-cap names and historically offers a somewhat higher dividend yield; VEA adds small caps plus Canadian and South Korean semiconductor exposure.
  • Tickeron AI Verdict: VEA — its cost efficiency, broader diversification, and inclusion of AI-memory leaders give it a structural edge in the current market cycle.

Introduction

Investors looking for international diversification often turn to one of two established developed-market ETFs: the iShares MSCI EAFE ETF (EFA) and the Vanguard FTSE Developed Markets ETF (VEA). Both target developed equity markets outside the United States, so they serve a similar role in many portfolios. Still, differences in country coverage, index construction, number of holdings, and costs matter. From what I see, understanding those details helps determine which one aligns better with an investor’s objectives, especially when an AI-driven approach is applied to the current environment.

A Closer Look at EFA

EFA seeks to track the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted measure of large- and mid-cap developed-market equities in Europe, Australasia, and the Far East. The index leaves out the United States and Canada, and because MSCI views South Korea as emerging, the fund has no exposure there. It uses optimized sampling to hold roughly 700 to 900 securities and carries an expense ratio of 0.32%. Top holdings center on European multinationals such as ASML, Roche, Shell, HSBC, Novartis, Nestlé, AstraZeneca, SAP, Mitsubishi UFJ Financial Group, and Siemens. Sector weights lean toward financials (about 24–26%), industrials (roughly 18–19%), information technology (around 10–11%), and healthcare (near 10%). Japan, the United Kingdom, France, Germany, Switzerland, and Australia form the main geographic anchors. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers.

A Closer Look at VEA

VEA follows the FTSE Developed All Cap ex US Index, which covers large-, mid-, and small-cap stocks across developed markets outside the United States. This benchmark includes Canada and South Korea and extends into small caps. The fund uses full replication and holds nearly 4,000 stocks, with its ten largest positions making up only about 10% of assets. Its expense ratio stands at just 0.03%. Because FTSE classifies South Korea as developed, top holdings feature Samsung Electronics and SK Hynix alongside ASML, HSBC, Novartis, Royal Bank of Canada, Roche, AstraZeneca, Nestlé, and Siemens. Sector exposure remains similar—financials near 24%, industrials about 19%, and technology around 11%—while country weights are led by Japan, the United Kingdom, and Canada, with the latter contributing roughly 11% of assets.

Industry and Thematic Context

Both ETFs operate in the international large-blend category and respond to the same macro drivers: central-bank rate decisions, currency fluctuations, European industrial trends, and the global semiconductor cycle. Artificial intelligence has become a notable theme, directing attention to semiconductor and chip-equipment suppliers in Europe and Asia. This dynamic favors funds with solid technology exposure. Developed-market equities continue to trade at a valuation discount to U.S. large caps, which can support periodic rotation into international benchmarks. Risks include currency swings, euro-area and Japanese economic softness, energy price changes, and geopolitical tensions affecting exporters.

Performance and Positioning

In recent periods the two ETFs have largely moved together, consistent with their shared mandate and overlapping holdings. Relative positioning has differed on two main points. VEA’s inclusion of South Korean memory-chip makers Samsung Electronics and SK Hynix has provided greater exposure to the AI and semiconductor cycle. Its Canadian allocation also adds stability through large financials and commodity-linked names that EFA does not hold. EFA has tended to deliver a modestly higher dividend yield and a purer large- and mid-cap focus. On a volatility-adjusted basis, VEA’s broader diversification and lower cost have supported slightly more consistent positioning across market regimes.

Exploring Tickeron’s AI Screener

When analyzing ETFs like these, I often turn to Tickeron’s AI Screener to filter securities by technical patterns, fundamentals, and AI-driven signals. The tool lets users scan thousands of names with customizable criteria such as industry, market cap, and performance metrics, helping surface relevant ideas more efficiently than manual review. In my view, running EFA and VEA through this process highlights how their structural differences play out in real time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EFA, VEA

EFA in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 01, 2026

EFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 41 cases where EFA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EFA just turned positive on October 15, 2026. Looking at past instances where EFA's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.

Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 60 cases where EFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFA as a result. In 66 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Spotify Technology SA (NYSE:SPOT), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Nokia Corp (NYSE:NOK), Nebius Group N.V. (NASDAQ:NBIS).

Industry description

The investment seeks to track the investment results of the MSCI EAFE Index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.

Market Cap

The average market capitalization across the iShares MSCI EAFE ETF (EFA) ETF is 48.03B. The market cap for tickers in the group ranges from 505.99M to 123.37B. SPOT holds the highest valuation in this group at 123.37B. The lowest valued company is HKD at 505.99M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 31%. For the same ETF, the average monthly price growth was 42%, and the average quarterly price growth was 106%. GRAB experienced the highest price growth at 15%, while USD experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 4%. For the same stocks of the ETF, the average monthly volume growth was 21% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 54
Price Growth Rating: 51
SMR Rating: 60
Profit Risk Rating: 59
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Category
Foreign Large Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Shares of CHH are declining approximately 13.00% on Thursday, April 30, 2026, falling from a prior close of $117.36 to approximately $102.10, as Q1 2026 earnings released after Wednesday's close delivered a severe adjusted EPS miss of $1.07 against the $1.32 analyst consensus — an 18.9% shortfall — while net income collapsed 54.4% year-over-year to $20.3 million from $44.5 million, confirming the worst fears of investors regarding the company's near-term profitability trajectory.
Shares of WAY are declining approximately 14.00% on Thursday, April 30, 2026, falling from a prior close of $25.27 to approximately $21.73 — approaching the stock's 52-week low of $21.09 set on April 10 — as Q1 2026 results released April 29 delivered a headline revenue beat that was immediately overshadowed by Q2 2026 sequential revenue guidance of flat to -1% growth, signaling that the momentum trajectory in healthcare payment software is decelerating materially.